Bionano Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
Portfolio Pulse from Benzinga Newsdesk
Bionano Genomics has regained compliance with Nasdaq's minimum bid price listing requirement. This comes after the company's stock price consistently met or exceeded the $1.00 minimum bid price requirement for at least ten consecutive business days.

August 21, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bionano Genomics has regained compliance with Nasdaq's minimum bid price listing requirement, which could boost investor confidence in the company.
Regaining compliance with Nasdaq's minimum bid price listing requirement is a positive development for Bionano Genomics. It removes the risk of delisting, which could have had a negative impact on the company's stock price. This news could boost investor confidence in the company, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100